WHO Publishes ‘Programmatic Update’ On Use Of ARVs To Treat Pregnant Women, Prevent PMTCT

The WHO “recently published a ‘Programmatic Update‘ [.pdf] on the use of antiretrovirals (ARVs) to treat pregnant women and prevent mother-to-child transmission of HIV (PMTCT),” the Center for Global Health Policy’s “Science Speaks” blog reports. “According to the executive summary, the WHO has started a comprehensive revision of all ARV guidelines, to include ARVs for pregnant women, which it plans to release in early 2013,” the blog notes (Mazzotta, 4/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.